Dr. Anna Efremidis, MD, FACP, Hematologist

EDUCATION

1971 M.D. Degree, summa cum laude, Medical School, University of Thessaloniki

1980 Doctor in Science, summa cum laude, Medical School, University of Thessaloniki

Post graduate training

72-73 Sub internship in Internal Medicine Hospital for Infectious Diseases, Thessaloniki, Greece.

73-74 Resident in Radiology, A.H.E.P.A University Hospital, Thessalonica, Greece.

74-77 Resident in Internal Medicine, Jewish Hospital and Medical Center , Downstate University of the State University of New York, USA.

ACADEMIC POSITIONS

1986-today Lecturer Dept.  Medical Oncology, Mount Sinai School of Medicine, State University of New York,  USA.                                                           

HONORS – AWARDS – LICENSES – CERTIFICATIONS – MEMBERSHIPS

2009 HONORARY PRIZE for Distinction in Clinical Research and Service in the Field of Breast Cancer Hellenic  Mastology  Society- GREECE

2001-2003 American Society Clinical Oncology (ASCO), Continuing Medical Education Committee (CME) Invited International Member. ASCO , Alexandria, VA, USA.

MEMBERSHIPS

American College of Physicians- USA Fellow (FACP)

American Society  of Clinical Oncology (ASCO)- USA Member

American Society of Hematology (ASH)- USA Member

European Society of medical Oncology (ESMO)- European Community Member

European Society for Stem Cell Transplantation-European Community Member

European Lung Cancer Working Party (ELCWP)-European Community Served as Board Member

EDITORIAL ACTIVITIES

Books (selected)

1. Barbounis V. Efremidis A.P. Neoadjuvant Chemotherapy in GI Malignancies. In Cancer of the GI Tract pp 135-141. Ed: Med. School Univ. Athens.Pashalides Press.  Athens 1992.

2. Efremidis A.P. Editor. Bonne Marrow Transplantation. Educat. Book pp1-109.  Ed: ESO. Delphi , 1994.

3. Efremidis A.P.  Chemotherapy in GI Malignancies. In Cancer of the GI Tract pp 231-236. Ed: Hellen. Cancer Soc. Athens 1994

4. Efremidis A.P. Editor. PSCT in Solid Tumors and Hematologic Malignancies pp 1- 305.Educational Book. Ed: ESO. Delphi 1997.

5. Hadjihristou E. Efremidis A.P. High Dose Chemotherapy in Germ Cell Tumors. In topics Med. Oncol .pp 269-273.Ed: Hellen. Soc. Med. Oncol. Athens 1998.

6. Vassilomanolakis M. Efremidis A.P. Megatherapy with Stem Cell Support in Breast Cancer. In Topics Med. Onc. Pp 274-280. Ed: Hellen. Soc. Med. Oncol. Athens 1998.

 Articles (selected)

1. Berghmans T, Lafitte JJ, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Leclercq N, Paesmans M, Sculier JP; European Lung Cancer Working Party.

Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party.

Br J Cancer. 2007 Jun 4;96(11):1644-9. Epub 2007 May 1.

2. Sculier JP, Lafitte JJ, Paesmans M, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Koumakis G, Vaslamatzis MM, Leclercq N, Berghmans T; European Lung Cancer Working Party.

 Chemotherapy improves low performance status lung cancer patients.

Eur Respir J. 2007 Dec;30(6):1186-92. Epub 2007 Au

3. Sculier JP, Lafitte JJ, Efremidis A, Florin MC, Lecomte J, Berchier MC, Richez M, Berghmans T, Scherpereel A, Meert AP, Koumakis G, Leclercq N, Paesmans M, Van Houtte P; European Lung Cancer Working Party (ELCWP).

 A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer.

Ann Oncol. 2008 Oct;19(10):1691-7. Epub 2008 May 25.

4. Terzidis A, Sergentanis TN, Antonopoulos G, Syrigos C, Efremidis A, Polyzos A, Dessypris N, Petridou ET. Elevated serum leptin levels: a risk factor for non-small-cell lung cancer?

Oncology. 2009;76(1):19-25. Epub 2008 Nov 24.

5. Fostira F, Papademitriou C, Efremidis A, Yannoukakos D.

An in-frame exon-skipping MUTYH mutation is associated with early-onset colorectal cancer.

Dis Colon Rectum. 2010 Aug;53(8):1197-2011.

6. Petridou ET, Sergentanis TN, Antonopoulos CN, Dessypris N, Matsoukis IL, Aronis K, Efremidis A, Syrigos C, Mantzoros CS.

Insulin resistance: an independent risk factor for lung cancer?

Metabolism. 2011 Aug;60(8):1100-6. Epub 2011 Jan 19.

7.Validation and comparison of several published prognostic systems for patients with small cell lung cancer.

Paesmans M, Lafitte JJ, Lecomte J, Berghmans T, Efremidis A, Giner V, Van Cutsem O, Scherpereel A, Meert AP, Leclercq N, Van Houtte P, Sculier JP.

Eur Respir J. 2011 Sep;38(3):657-63. Epub 2011 May 26.